XML 23 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2020
Stock-Based Compensation  
Stock-Based Compensation

6. Stock Based Compensation

Our Board of Directors (the Board) and the requisite stockholders previously approved the 2010 Equity Incentive Plan (the 2010 Plan). In October 2013, the Board approved the 2013 Equity Incentive Plan (the 2013 Plan) and in November 2013 our stockholders approved the 2013 Plan which became effective as of December 3, 2013. As of December 2, 2013, we suspended the 2010 Plan and no additional awards may be granted under the 2010 Plan. Any shares of common stock covered by awards granted under the 2010 Plan that terminate after December 2, 2013 by expiration, forfeiture, cancellation or other means without the issuance of such shares will be added to the 2013 Plan reserve.

As of June 30, 2020, the total number of shares of common stock available for issuance under the 2013 Plan is 12,116,313, which includes 2,684,456 shares of common stock that were available for issuance under the 2010 Plan as of the effective date of the 2013 Plan. Unless otherwise determined by the Board, beginning January 1, 2014, and continuing until the expiration of the 2013 Plan, the total number of shares of common stock available for issuance under the 2013 Plan will automatically increase annually on January 1 of each year by 4% of the total number of issued and outstanding shares of common stock as of December 31 of the immediate preceding year. Pursuant to approval by the Board, the total number of shares of common stock available for issuance under the 2013 Plan was increased by 1,138,046 shares on January 1, 2020. As of June 30, 2020, a total of 10,327,214 shares of common stock subject to options have been granted under the 2013 Plan.

In November 2013, the Board and our stockholders approved the 2013 Employee Stock Purchase Plan (ESPP), which became effective as of December 5, 2013. We have reserved a total of 581,286 shares of common stock for issuance under the ESPP. Unless otherwise determined by the Board, beginning on January 1, 2014, and continuing until the expiration of the ESPP, the total number of shares of common stock available for issuance under the ESPP will automatically increase annually on January 1 by the lesser of (i) 1% of the total number of issued and outstanding shares of common stock as of December 31 of the immediately preceding year, or (ii) 621,814 shares of common stock. Pursuant to approval by our Board of Directors, there was no increase in the number of authorized shares in the ESPP from 2015 to 2020. As of June 30, 2020, we have issued a total of 445,621 shares of common stock under the ESPP.

During the six months ended June 30, 2020, the Company awarded 305,794 Restricted Stock Units (RSUs) to certain employees. Vesting of these awards is in three equal annual installments and is contingent on continued service to the Company. The fair value of these awards is determined based on the intrinsic value of the stock on the date of grant and will be recognized as stock-based compensation expense over the requisite service period. As of June 30, 2020, we have granted a total of 411,293 shares of common stock subject to RSUs.

Total employee, director and non-employee stock-based compensation expense recognized for the three and six months ended June 30, 2020 and 2019 are as follows (in thousands):

Three Months Ended

 

Six Months Ended

June 30, 

 

June 30, 

    

2020

    

2019

 

2020

    

2019

General and administrative

$

2,804

$

2,008

$

5,095

$

3,862

Research and development

 

5,427

 

7,295

 

9,648

 

11,297

$

8,231

$

9,303

$

14,743

$

15,159

Three Months Ended

Six Months Ended

June 30, 

June 30, 

2020

    

2019

2020

    

2019

Stock options

$

6,667

$

8,946

$

12,549

$

14,470

ESPP

213

195

407

413

Restricted stock units

1,351

162

1,787

276

$

8,231

$

9,303

$

14,743

$

15,159

The following table summarizes option activity under our stock plans and related information:

    

    

    

Weighted

 

Weighted

Average

 

Average

Number of

Exercise

 

Remaining

Aggregate

Shares Subject

Price

 

Contractual

Intrinsic

to Outstanding

(Per

 

Term

Value

Options

Share)

 

(in years)

(in thousands)

Balances at December 31, 2019

 

7,174,319

$

24.03

7.32

Options granted

 

1,433,699

$

32.10

Options forfeited

 

(115,261)

$

31.28

Options exercised

 

(261,786)

$

18.13

Balances at June 30, 2020

 

8,230,971

$

25.52

7.33

$

65,362

Exercisable

4,587,110

$

20.28

6.10

$

58,544

We calculate the intrinsic value as the difference between the exercise price of the options and the closing price of common stock of $32.39 per share as of June 30, 2020.

Weighted-average fair value of options granted during the six-month periods ended June 30, 2020 and 2019 were $16.44 and $20.74 per share, respectively. There were 1,700,583 options granted during the six-month period ended June 30, 2019. We estimated the fair value of each stock option using the Black-Scholes option-pricing model based on the date of grant of such stock option with the following weighted average assumptions for the three and six months ended June 30, 2020 and 2019:

Options

Options

 

Three Months Ended

Six Months Ended

June 30, 

June 30, 

 

    

2020

    

2019

    

2020

    

2019

 

Expected term (years)

5.7

 

5.9

6.2

 

6.0

Expected volatility

56.1

%

61.3

%

54.3

%  

61.3

%

Risk-free interest rate

0.41

%

2.07

%

0.84

%  

2.43

%

Expected dividend yield

%  

%  

%  

%  

ESPP

ESPP

 

Three Months Ended

Six Months Ended

 

June 30, 

June 30, 

 

    

2020

    

2019

    

2020

    

2019

 

Expected term (years)

 

0.5 - 2.0

 

0.5 - 2.0

0.5 - 2.0

 

0.5 - 2.0

Expected volatility

50.8 - 62.6

%

55.0 - 71.4

%

50.8 - 62.6

%

55.0 - 71.4

%

Risk-free interest rate

 

0.18 - 1.65

%

1.47 - 2.70

%

0.18 - 1.65

%

1.47 - 2.70

%

Expected dividend yield

%

%

%

%

As of June 30, 2020, the unamortized compensation expense related to unvested stock options was $59.4 million. The remaining unamortized compensation expense will be recognized over the next 2.8 years. As of June 30, 2020, the unamortized compensation expense under our ESPP was $1.3 million. The remaining unamortized expense will be recognized over the next 1.4 years.

The following table summarizes the RSU activity for the six-month period ended June 30, 2020:

Weighted

Restricted

Average Grant

Stock

Date Fair Value

Units

(Per unit)

Unvested at December 31, 2019

 

90,006

$

34.66

Granted

 

305,794

31.64

Vested

 

(21,822)

31.91

Forfeited

 

(7,311)

31.47

Unvested at June 30, 2020

 

366,667

$

32.37

As of June 30, 2020, the unamortized compensation expense related to unvested RSUs was $10.2 million. The remaining unamortized expense will be recognized over the next 2.3 years.